India to South Africa: Allopurinol Export Trade Route
India has recorded 126 verified shipments of Allopurinol exported to South Africa, representing a combined trade value of $4.7M USD. This corridor is served by 13 active Indian exporters, with an average shipment value of $37.0K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 68% of total export value with 37 shipments worth $3.2M USD. On the buying side, NA is the largest importer in South Africa with $3.2M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, INDOCO REMEDIES LIMITED, ADCOCK INGRAM LIMITED — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to South Africa Allopurinol corridor is one of India's established pharmaceutical export routes, with 126 shipments documented worth a combined $4.7M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 68% of all export value, reflecting the consolidated nature of India's allopurinol manufacturing sector.
Across 13 active suppliers, the average shipment value stands at $37.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with allopurinol's non-urgent bulk-order profile.
Shipment activity peaks during January-March, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 9.39%, placing it at rank #2 among India's top allopurinol export destinations globally.
On the import side, key buyers of Indian allopurinol in South Africa include NA, ADCOCK INGRAM LIMITED, TO THE ORDER and 15 others. NA is the single largest importer with 41 shipments valued at $3.2M USD.
